Diede Brunen

Critic
DISC Type : C

Principal at BGV (BioGeneration Ventures)

Naarden, North Holland, Netherlands

Overview

Diede is a Principal at BGV, a life sciences venture capital firm, where he evaluates and structures new investment opportunities. He leverages a deep scientific background, including a PhD from the Netherlands Cancer Institute focusing on oncology, to guide early-stage biotech companies. He also serves as a non-executive board member for portfolio companies like ARTICA Therapeutics.

He appears passionate about translating scientific discovery into patient value, bridging the gap between academic research and business. Diede actively engages with the scientific and business communities, attending major industry conferences like ESMO and speaking to students about careers in venture capital, demonstrating a commitment to fostering the next generation of talent.

Before moving to venture capital, Diede co-authored research papers on novel cancer therapy targets and synthetic lethality.

Personality Overview

ROI Driven

Critic

Information Seeker

They prefer to analyze logically and value objective facts over emotions.  They are quite likely to negotiate on pricing or other key terms. They don’t appreciate bells and whistles unless backed by data.

Topics They Care About

Life Sciences Investing
As a Principal at BGV, he is responsible for deal flow, company creation, and structuring new investments in early-stage European biotech firms.
Autoimmune Therapies
He is a board member at ARTICA Therapeutics, a portfolio company developing novel covalent small molecules for autoimmune and inflammatory disorders.
Oncology Research
His PhD research at the Netherlands Cancer Institute focused on using genetic screens to identify novel synthetic lethality targets for cancer therapy.

Media Appearances

Diede has no verified media appearances

Work History

4-2023
Principal at BGV (BioGeneration Ventures)
12-2021 - 3-2023
Senior Associate at BGV (BioGeneration Ventures)
1-2020 - 12-2021
Associate at BGV (BioGeneration Ventures)
12-2022
Board Director at ARTICA Therapeutics
7-2021 - 12-2022
Board Observer at ARTICA Therapeutics

Education

2012 - 2017
Doctor of Philosophy - PhD from Utrecht University
2009 - 2012
Master of Science (M.Sc.) from Utrecht University

More Information

Social Presence :

Prographics :

Exp : 6 Location : Naarden, North Holland, Netherlands Job Level : Middle Designation : Principal at BGV (BioGeneration Ventures)
URL has been copied!

Insights For Selling To Diede

During A Call Or A Meeting

DO's

  • Be ready to answer many clarity-seeking questions and requests for information
  • If you can, show them industry reports or analyst comments instead of sharing anecdotal stories
  • Leverage facts and figures wherever possible; use percentages, numbers etc.

DONT's

  • Avoid phrases like ‘trust me’, ‘others just love’ etc.
  • Make extra effort to not seem pushy or confrontational
  • Don't give superficial answers, they are easily rattled by them

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Diede is

  • Proof of ROI, low pricing and objective proof points are the important factors for them.
  • Will you ever get a clear answer from Diede

  • They do not mind saying no if they believe that it is the right decision.

Insights For Deal Planning

    How fast (or slow) will Diede move?

  • They are neither the fastest nor the slowest decision makers, they are somewhere in the middle.
  • Can Diede take some risk or not?

  • They can bear some risk if their analysis backs the decision.

You And Diede

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.